{"id":9742,"date":"2026-04-01T10:08:12","date_gmt":"2026-04-01T02:08:12","guid":{"rendered":"https:\/\/regask.com\/?p=9742"},"modified":"2026-04-01T10:08:12","modified_gmt":"2026-04-01T02:08:12","slug":"lagence-bresilienne-des-visas-anvisa-met-a-jour-ses-informations-sur-les-souches-de-vaccins-contre-la-covid-19-les-medicaments-a-faible-risque-et-les-regles-relatives-aux-ingredients","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","title":{"rendered":"L&#039;agence br\u00e9silienne ANVISA fait le point sur les souches de vaccins contre la COVID-19, \u00e0 faible risque\u2026"},"content":{"rendered":"<p>Sur <strong>24 mars 2026,<\/strong> le <strong>Agence nationale br\u00e9silienne de surveillance sanitaire (ANVISA)<\/strong> a annonc\u00e9 une s\u00e9rie de mises \u00e0 jour r\u00e9glementaires ayant un impact sur<strong> Composition du vaccin contre la COVID-19, proc\u00e9dures de notification des m\u00e9dicaments \u00e0 faible risque, ingr\u00e9dients des compl\u00e9ments alimentaires et restrictions relatives aux produits cosm\u00e9tiques.<\/strong> Les changements s&#039;appliquent \u00e0 <strong>fabricants de produits pharmaceutiques, producteurs de compl\u00e9ments alimentaires et entreprises cosm\u00e9tiques<\/strong> op\u00e9rant au Br\u00e9sil.<\/p>\n<div class=\"row\"  id=\"row-889366934\">\n\n\t<div id=\"col-925409473\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-2000566475\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2000566475 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>D\u00e9tails de la mise \u00e0 jour<\/h2>\n\t<div id=\"gap-630334335\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-630334335 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">La mise \u00e0 jour introduit de la flexibilit\u00e9 dans\u00a0<\/span><b><span data-contrast=\"auto\">Composition du vaccin contre la COVID-19<\/span><\/b><span data-contrast=\"auto\">, permettant aux vaccins d&#039;inclure soit le\u00a0<\/span><b><span data-contrast=\"auto\">LP.8.1<\/span><\/b><span data-contrast=\"auto\">\u00a0ou\u00a0<\/span><b><span data-contrast=\"auto\">Souches virales JN.1<\/span><\/b><span data-contrast=\"auto\">, la s\u00e9lection finale \u00e9tant soumise au pouvoir discr\u00e9tionnaire du minist\u00e8re de la Sant\u00e9.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Parall\u00e8lement, l&#039;ANVISA a \u00e9largi le champ d&#039;application de\u00a0<\/span><b><span data-contrast=\"auto\">M\u00e9dicaments \u00e0 faible risque \u00e9ligibles \u00e0 une notification simplifi\u00e9e avant commercialisation<\/span><\/b><span data-contrast=\"auto\">, y compris maintenant\u00a0<\/span><b><span data-contrast=\"auto\">povidone iod\u00e9e, parac\u00e9tamol, sim\u00e9thicone et sous-salicylate de bismuth<\/span><\/b><span data-contrast=\"auto\">, en rationalisant les proc\u00e9dures d&#039;autorisation r\u00e9glementaires pour ces produits.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">L&#039;agence a \u00e9galement autoris\u00e9 de nouvelles\u00a0<\/span><b><span data-contrast=\"auto\">ingr\u00e9dients de compl\u00e9ments alimentaires<\/span><\/b><span data-contrast=\"auto\">, y compris\u00a0<\/span><b><span data-contrast=\"auto\">huile de noix de Baru<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">huile de microalgues contenant du DHA (<\/span><\/b><b><i><span data-contrast=\"auto\">Schizochytrium<\/span><\/i><\/b><b><span data-contrast=\"auto\">\u00a0sp.)<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">concentr\u00e9 d&#039;a\u00e7a\u00ef lyophilis\u00e9<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">Bifidobacterium animalis sous-esp\u00e8ce. lactis<\/span><\/b><span data-contrast=\"auto\">, et\u00a0<\/span><b><span data-contrast=\"auto\">Streptococcus salivarius K12<\/span><\/b><span data-contrast=\"auto\">. Ces ingr\u00e9dients sont soumis \u00e0\u00a0<\/span><b><span data-contrast=\"auto\">limites d&#039;utilisation d\u00e9finies et exigences d&#039;\u00e9tiquetage<\/span><\/b><span data-contrast=\"auto\">, renfor\u00e7ant les obligations de conformit\u00e9.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">De plus, l&#039;ANVISA a r\u00e9affirm\u00e9\u00a0<\/span><b><span data-contrast=\"auto\">interdiction des produits pour les ongles contenant de l&#039;oxyde de diph\u00e9nyl(2,4,6-trim\u00e9thylbenzoyl)phosphine (TPO) et de la N,N-dim\u00e9thyl-p-toluidine (DMPT)<\/span><\/b><span data-contrast=\"auto\">. La restriction reste en vigueur malgr\u00e9 tout recours en cours, confirmant ainsi son application stricte.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-925409473 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-871158325\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Date d&#039;entr\u00e9e en vigueur<\/h2>\n\t<div id=\"gap-1003620640\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1003620640 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">Les mises \u00e0 jour r\u00e9glementaires \u00e9taient\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">annonc\u00e9 le 24 mars 2026<\/span><\/span><span class=\"TextRun SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">.<\/span><\/span><span class=\"EOP SCXW194959746 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-871158325 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-359422537\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pourquoi c&#039;est important<\/h2>\n\t<div id=\"gap-725021540\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-725021540 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Ces mises \u00e0 jour am\u00e9liorent<strong> clart\u00e9 r\u00e9glementaire<\/strong> en d\u00e9finissant les souches vaccinales admissibles et les ingr\u00e9dients autoris\u00e9s, tout en soutenant<strong> efficacit\u00e9 num\u00e9rique et proc\u00e9durale<\/strong> par le biais de proc\u00e9dures de notification simplifi\u00e9es pour les m\u00e9dicaments \u00e0 faible risque. Parall\u00e8lement, le maintien de l&#039;application des restrictions relatives aux produits cosm\u00e9tiques garantit <strong>normes de conformit\u00e9 coh\u00e9rentes<\/strong> avec un minimum de contraintes r\u00e9glementaires suppl\u00e9mentaires pour les produits conformes.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-359422537 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1666661686\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Qui est concern\u00e9 ?<\/h2>\n\t<div id=\"gap-1116175561\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1116175561 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">Cette mise \u00e0 jour est pertinente pour<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">\u00e9quipes des affaires r\u00e9glementaires, de l&#039;assurance qualit\u00e9, de la R&amp;D et de la conformit\u00e9<\/span><\/span><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">,<\/span><\/span><\/strong><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\"> ainsi que <\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">\u00e9quipes informatiques et de transformation num\u00e9rique<\/span><\/span><\/strong><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">\u00a0responsable de la gestion des flux de travail r\u00e9glementaires et des donn\u00e9es produits pour les portefeuilles pharmaceutiques, de compl\u00e9ments alimentaires et de cosm\u00e9tiques.<\/span><\/span><span class=\"EOP SCXW220643823 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1666661686 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1658587103\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Prochaines \u00e9tapes<\/h2>\n\t<div id=\"gap-634710627\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-634710627 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Les entreprises devraient\u00a0<\/span><b><span data-contrast=\"auto\">\u00e9valuer les portefeuilles de produits actuels<\/span><\/b><span data-contrast=\"auto\">\u00a0Les parties prenantes doivent se conformer aux exigences actualis\u00e9es, notamment en ce qui concerne les options de composition des vaccins, l&#039;admissibilit\u00e9 \u00e0 la notification des m\u00e9dicaments \u00e0 faible risque, les ingr\u00e9dients autoris\u00e9s des compl\u00e9ments alimentaires et les restrictions relatives aux substances cosm\u00e9tiques. Elles doivent se coordonner.\u00a0<\/span><b><span data-contrast=\"auto\">revues interfonctionnelles<\/span><\/b><span data-contrast=\"auto\">\u00a0mettre \u00e0 jour les documents r\u00e9glementaires, les pratiques d&#039;\u00e9tiquetage et les contr\u00f4les de la cha\u00eene d&#039;approvisionnement afin d&#039;assurer une conformit\u00e9 continue avec la r\u00e9glementation de l&#039;ANVISA.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Face \u00e0 des mises \u00e0 jour r\u00e9glementaires de plus en plus fr\u00e9quentes et complexes dans de multiples cat\u00e9gories de produits, les organisations peuvent tirer profit d&#039;une intelligence centralis\u00e9e et de l&#039;automatisation pour garder une longueur d&#039;avance sur les changements.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/fr\/\">RegASK<\/a>\u00a0est une plateforme de pointe d&#039;intelligence r\u00e9glementaire et d&#039;orchestration des flux de travail bas\u00e9e sur l&#039;IA agentielle<\/span><\/b><span data-contrast=\"auto\">\u00a0qui permet aux organisations internationales op\u00e9rant dans des secteurs fortement r\u00e9glement\u00e9s, tels que les produits de consommation et les sciences de la vie, d&#039;anticiper et de g\u00e9rer des environnements r\u00e9glementaires complexes. En combinant une IA agentique avanc\u00e9e et l&#039;expertise de sp\u00e9cialistes,\u00a0<a href=\"http:\/\/regask.com\/fr\/\">RegASK<\/a>\u00a0Elle fournit en temps opportun des informations pr\u00e9dictives exploitables et une automatisation de bout en bout, rationalisant les processus de conformit\u00e9, att\u00e9nuant les risques et acc\u00e9l\u00e9rant l&#039;acc\u00e8s au march\u00e9 dans plus de 160 pays.\u00a0<\/span><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/fr\/\">En savoir plus<\/a> ou <a href=\"https:\/\/regask.com\/fr\/reserver-une-demo\/\">r\u00e9servez une d\u00e9mo maintenant.<\/a><\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1658587103 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-730823140\">\n\n\t<div id=\"col-165946225\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>FAQ<\/h3>\n\t<div id=\"gap-672533052\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-672533052 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW85757934 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85757934 BCX0\">Quelles sont les souches de COVID-19 ?\u00a0<\/span><span class=\"NormalTextRun SCXW85757934 BCX0\">permis<\/span><span class=\"NormalTextRun SCXW85757934 BCX0\">\u00a0conform\u00e9ment aux directives actualis\u00e9es de l&#039;ANVISA\u00a0?<\/span><\/span><span class=\"EOP SCXW85757934 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-315619066\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-315619066 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\">Les vaccins contre la COVID-19 peuvent inclure soit le\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\">Souches virales LP.8.1 ou JN.1<\/span><\/span><\/strong><span class=\"TextRun SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\"><strong>,<\/strong> avec final\u00a0<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">s\u00e9lection<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">d\u00e9termin\u00e9<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">\u00a0par le minist\u00e8re de la Sant\u00e9.<\/span><\/span><span class=\"EOP SCXW132553472 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-165946225 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1268251207\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW177685408 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW177685408 BCX0\">Quels m\u00e9dicaments sont \u00e9ligibles \u00e0 une notification simplifi\u00e9e au Br\u00e9sil\u00a0?<\/span><\/span><span class=\"EOP SCXW177685408 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1949877704\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1949877704 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><strong><span class=\"TextRun MacChromeBold SCXW62415161 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW62415161 BCX0\">Povidone iod\u00e9e, parac\u00e9tamol, sim\u00e9thicone et sous-salicylate de bismuth<\/span><\/span><\/strong><span class=\"TextRun SCXW62415161 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW62415161 BCX0\">\u00a0sont d\u00e9sormais \u00e9ligibles \u00e0 une notification simplifi\u00e9e en tant que m\u00e9dicaments \u00e0 faible risque avant leur commercialisation.<\/span><\/span><span class=\"EOP SCXW62415161 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1268251207 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1707374572\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW147526865 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW147526865 BCX0\">Quels sont les nouveaux ingr\u00e9dients autoris\u00e9s dans les compl\u00e9ments alimentaires ?<\/span><\/span><span class=\"EOP SCXW147526865 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-854507175\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-854507175 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Les ingr\u00e9dients autoris\u00e9s comprennent\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">huile de noix de Baru<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">huile de microalgues avec DHA (<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SpellingErrorV2Themed SCXW152755442 BCX0\">Schizochytrium<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">\u00a0sp.)<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">concentr\u00e9 d&#039;a\u00e7a\u00ef lyophilis\u00e9<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Bifidobacterium\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW152755442 BCX0\">animalis<\/span><span class=\"NormalTextRun SCXW152755442 BCX0\">\u00a0subsp. lactis<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">, et\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Streptococcus salivarius K12<\/span><\/span><\/strong><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\"><strong>,<\/strong> sous r\u00e9serve des limites d&#039;utilisation et des exigences d&#039;\u00e9tiquetage.<\/span><\/span><span class=\"EOP SCXW152755442 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1707374572 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1444186775\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW204239453 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW204239453 BCX0\">Comment peut-on\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW204239453 BCX0\">RegASK<\/span><span class=\"NormalTextRun SCXW204239453 BCX0\">\u00a0Besoin d&#039;aide pour les mises \u00e0 jour de conformit\u00e9 TITCK\u00a0?<\/span><\/span><span class=\"EOP SCXW204239453 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-965335962\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-965335962 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/fr\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW193127493 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW193127493 BCX0\">\u00a0aide les organisations\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW193127493 BCX0\">Suivez les changements r\u00e9glementaires en temps r\u00e9el, \u00e9valuez leur impact sur les produits et rationalisez les processus de conformit\u00e9.<\/span><\/span><\/strong><span class=\"TextRun SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW193127493 BCX0\"><strong>,<\/strong> permettre une adaptation plus rapide \u00e0\u00a0<\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW193127493 BCX0\">mises \u00e0 jour<\/span><span class=\"NormalTextRun SCXW193127493 BCX0\">\u00a0comme des modifications de la composition des vaccins, des autorisations d&#039;ingr\u00e9dients et des restrictions de produits au Br\u00e9sil.<\/span><\/span><span class=\"EOP SCXW193127493 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1444186775 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On March 24, 2026, the Brazilian National Health Surveillance Agency (ANVISA) announced a set of regulatory updates impacting COVID-19 vaccine composition, low-risk medicines notification procedures, dietary supplement ingredients, and cosmetic product restrictions. The changes apply to pharmaceutical manufacturers, dietary supplement producers, and cosmetic companies operating in Brazil.<\/p>","protected":false},"author":41,"featured_media":9743,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,512,35],"tags":[],"class_list":["post-9742","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-brazil-regulations","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Brazil ANVISA Updates COVID-19 Vaccine Strains and Rules<\/title>\n<meta name=\"description\" content=\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/lagence-bresilienne-des-visas-anvisa-met-a-jour-ses-informations-sur-les-souches-de-vaccins-contre-la-covid-19-les-medicaments-a-faible-risque-et-les-regles-relatives-aux-ingredients\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Risk Medicines, and Ingredient Rules\" \/>\n<meta property=\"og:description\" content=\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/lagence-bresilienne-des-visas-anvisa-met-a-jour-ses-informations-sur-les-souches-de-vaccins-contre-la-covid-19-les-medicaments-a-faible-risque-et-les-regles-relatives-aux-ingredients\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-01T02:08:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\"},\"headline\":\"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Ris&hellip;\",\"datePublished\":\"2026-04-01T02:08:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"},\"wordCount\":749,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"articleSection\":[\"Regulatory News\",\"Brazil\",\"Pharma and Biotech\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\",\"name\":\"Brazil ANVISA Updates COVID-19 Vaccine Strains and Rules\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"datePublished\":\"2026-04-01T02:08:12+00:00\",\"description\":\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"width\":800,\"height\":600,\"caption\":\"Brazil Anvisa Updates Covid 19 Vaccine Strains Low Risk Medicines And Ingredient Rules\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\",\"name\":\"Shaffa Renaningtyas\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L&#039;ANVISA br\u00e9silienne met \u00e0 jour les souches et les r\u00e8gles relatives aux vaccins contre la COVID-19.","description":"D\u00e9couvrez les derni\u00e8res mises \u00e0 jour de l&#039;ANVISA br\u00e9silienne concernant les souches de vaccins contre la COVID-19 et les nouvelles r\u00e8gles relatives aux m\u00e9dicaments et ingr\u00e9dients \u00e0 faible risque.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/lagence-bresilienne-des-visas-anvisa-met-a-jour-ses-informations-sur-les-souches-de-vaccins-contre-la-covid-19-les-medicaments-a-faible-risque-et-les-regles-relatives-aux-ingredients\/","og_locale":"fr_FR","og_type":"article","og_title":"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Risk Medicines, and Ingredient Rules","og_description":"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.","og_url":"https:\/\/regask.com\/fr\/lagence-bresilienne-des-visas-anvisa-met-a-jour-ses-informations-sur-les-souches-de-vaccins-contre-la-covid-19-les-medicaments-a-faible-risque-et-les-regles-relatives-aux-ingredients\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-04-01T02:08:12+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#article","isPartOf":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6"},"headline":"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Ris&hellip;","datePublished":"2026-04-01T02:08:12+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"},"wordCount":749,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","articleSection":["Regulatory News","Brazil","Pharma and Biotech"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","url":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","name":"L&#039;ANVISA br\u00e9silienne met \u00e0 jour les souches et les r\u00e8gles relatives aux vaccins contre la COVID-19.","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","datePublished":"2026-04-01T02:08:12+00:00","description":"D\u00e9couvrez les derni\u00e8res mises \u00e0 jour de l&#039;ANVISA br\u00e9silienne concernant les souches de vaccins contre la COVID-19 et les nouvelles r\u00e8gles relatives aux m\u00e9dicaments et ingr\u00e9dients \u00e0 faible risque.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","width":800,"height":600,"caption":"Brazil Anvisa Updates Covid 19 Vaccine Strains Low Risk Medicines And Ingredient Rules"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Favoriser des d\u00e9cisions r\u00e9glementaires plus intelligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6","name":"Shaffa Renaningtyas"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=9742"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/9742\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/9743"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=9742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=9742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=9742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}